Table of Contents
HPB Surgery
Volume 2014, Article ID 437159, 6 pages
http://dx.doi.org/10.1155/2014/437159
Research Article

Use of Pharmacologic Agents for Modulation of Ischaemia-Reperfusion Injury after Hepatectomy: A Questionnaire Study of the LiverMetSurvey International Registry of Hepatic Surgery Units

1Hepato-Pancreato-Biliary Surgery Unit, Manchester Royal Infirmary, Manchester M13 9WL, UK
2Centre Hépato-Biliare, Hôpital Paul-Brousse, 12 Avenue Paul Vaillant Couturier, 94800 Villejuif, France

Received 15 May 2014; Accepted 22 October 2014; Published 12 November 2014

Academic Editor: Georgios Glantzounis

Copyright © 2014 Santhalingam Jegatheeswaran et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. B. Adams, T. A. Aloia, E. Loyer, T. M. Pawlik, B. Taouli, and J.-N. Vauthey, “Selection for hepatic resection of colorectal liver metastases: expert consensus statement,” HPB, vol. 15, no. 2, pp. 91–103, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. O. J. Garden, M. Rees, G. J. Poston et al., “Guidelines for resection of colorectal cancer liver metastases,” Gut, vol. 55, supplement 3, pp. iii1–iii8, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Jegatheeswaran, A. J. Sheen, and A. K. Siriwardena, “Contemporary management of perihilar cholangiocarcinoma in a nontransplant hepatopancreatobiliary center,” European Journal of Gastroenterology and Hepatology, vol. 25, no. 9, pp. 1099–1104, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. J. B. Hanks, W. C. Meyers, H. C. Filston, P. G. Killenberg, and R. S. Jones, “Surgical resection for benign and malignant liver disease,” Annals of Surgery, vol. 191, no. 5, pp. 584–592, 1980. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Adam, V. Delvart, G. Pascal et al., “Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival,” Annals of Surgery, vol. 240, no. 4, pp. 644–658, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Robles, C. Marín, A. Lopez-Conesa, A. Capel, D. Perez-Flores, and P. Parrilla, “Comparative study of right portal vein ligation versus embolisation for induction of hypertrophy in two-stage hepatectomy for multiple bilateral colorectal liver metastases,” European Journal of Surgical Oncology, vol. 38, no. 7, pp. 586–593, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. US Cancer statistics Working Group, United States Cancer Statistics: 1999-2009 Incidence and Mortality Web-Based Report, Department of Health and Human Services, Centres for Disease Control and Prevention and National Cancer Institute, Atlanta, Ga, USA, 2013, http://www.cdc.gov/uscs.
  8. J.-N. Vauthey, T. M. Pawlik, D. Ribero et al., “Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases,” Journal of Clinical Oncology, vol. 24, no. 13, pp. 2065–2072, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Brouquet, M. M. Mortenson, J.-N. Vauthey et al., “Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy?” Journal of the American College of Surgeons, vol. 210, no. 6, pp. 934–941, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. M. A. Choti, J. V. Sitzmann, M. F. Tiburi et al., “Trends in long-term survival following liver resection for hepatic colorectal metastases,” Annals of Surgery, vol. 235, no. 6, pp. 759–766, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Laca, J. Olejnik, M. Vician, B. Grandtnerova, and V. Zahradnik, “The effects of occlusive techniques on the short-term prognosis after liver resections,” Hepato-Gastroenterology, vol. 53, no. 70, pp. 576–579, 2006. View at Google Scholar · View at Scopus
  12. M. Kretzschmar, A. Krüger, and W. Schirrmeister, “Hepatic ischemia-reperfusion syndrome after partial liver resection (LR): hepatic venous oxygen saturation, enzyme pattern, reduced and oxidized glutathione, procalcitonin and interleukin-6,” Experimental and Toxicologic Pathology, vol. 54, no. 5-6, pp. 423–431, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. O. Scatton, S. Zalinski, D. Jegou et al., “Randomized clinical trial of ischaemic preconditioning in major liver resection with intermittent Pringle manoeuvre,” British Journal of Surgery, vol. 98, no. 9, pp. 1236–1243, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. G. K. Glantzounis, W. Yang, R. S. Koti, D. P. Mikhailidis, A. M. Seifalian, and B. R. Davidson, “Continuous infusion of N-acetylcysteine reduces liver warm ischaemia-reperfusion injury,” British Journal of Surgery, vol. 91, no. 10, pp. 1330–1339, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Decker, “Biologically active products of stimulated liver macrophages (Kupffer cells),” European Journal of Biochemistry, vol. 192, no. 2, pp. 245–261, 1990. View at Publisher · View at Google Scholar · View at Scopus
  16. B. P. Yu, “Cellular defenses against damage from reactive oxygen species,” Physiological Reviews, vol. 74, no. 1, pp. 139–162, 1994. View at Google Scholar · View at Scopus
  17. W. Davis Jr., Z. Ronai, and K. D. Tew, “Cellular thiols and reactive oxygen species in drug-induced apoptosis,” Journal of Pharmacology and Experimental Therapeutics, vol. 296, no. 1, pp. 1–6, 2001. View at Google Scholar · View at Scopus
  18. M. Zafarullah, W. Q. Li, J. Sylvester, and M. Ahmad, “Molecular mechanisms of N-acetylcysteine actions,” Cellular and Molecular Life Sciences, vol. 60, no. 1, pp. 6–20, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Nakano, H. Nagasaki, K. Yoshida et al., “N-acetylcysteine and anti-ICAM-1 monoclonal antibody reduce ischemia-reperfusion injury of the steatotic rat liver,” Transplantation Proceedings, vol. 30, no. 7, p. 3763, 1998. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Nagasaki, H. Nakano, K. Boudjema et al., “Efficacy of preconditioning with n-acetylcysteine against reperfusion injury after prolonged cold ischaemia in rats liver in which glutathione had been reduced by buthionine sulphoximine,” European Journal of Surgery, vol. 164, no. 2, pp. 139–146, 1998. View at Publisher · View at Google Scholar · View at Scopus
  21. L. F. Prescott, J. Park, A. Ballantyne, P. Adriaenssens, and A. T. Proudfoot, “Treatment of paracetamol (acetaminophen) poisoning with N-acetylcysteine,” The Lancet, vol. 2, no. 8035, pp. 432–434, 1977. View at Publisher · View at Google Scholar · View at Scopus
  22. L. F. Prescott, R. N. Illingworth, J. A. J. H. Critchley, and A. T. Proudfoot, “Intravenous N-acetylcysteine: still the treatment of choice for paracetamol poisoning,” British Medical Journal, vol. 280, no. 6206, pp. 46–47, 1980. View at Google Scholar · View at Scopus
  23. H. Sheth, G. Glantzounis, T. Hafez, A. Quaglia, J. Duncan, and B. R. Davidson, “Does perioperative N-acetylcysteine prevent ischemia reperfusion injury during liver resection?” Gut, vol. 54, supplement 2, p. 148, 2005. View at Google Scholar
  24. S. M. Robinson, R. Saif, G. Sen et al., “N-acetylcysteine administration does not improve patient outcome after liver resection,” HPB, vol. 15, no. 6, pp. 457–462, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Jegatheeswaran and K. Siriwardena, “Experimental and clinical evidence for modification of hepatic ischaemia-reperfusion injury by N-acetylcysteine during major liver surgery,” HPB, vol. 13, no. 2, pp. 71–78, 2011. View at Publisher · View at Google Scholar · View at Scopus